These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 19167633

  • 1. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M.
    J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
    [Abstract] [Full Text] [Related]

  • 2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 3. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
    Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
    [Abstract] [Full Text] [Related]

  • 4. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Hashino K, Ishii M, Iemura M, Akagi T, Kato H.
    Pediatr Int; 2001 Jun; 43(3):211-7. PubMed ID: 11380911
    [Abstract] [Full Text] [Related]

  • 5. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ, Chiu CH.
    Ann Trop Paediatr; 2004 Mar; 24(1):89-93. PubMed ID: 15005973
    [Abstract] [Full Text] [Related]

  • 6. [Steroid pulse therapy].
    Miura M.
    Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
    [Abstract] [Full Text] [Related]

  • 7. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 8. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 9. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA, Stephens I.
    Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
    [Abstract] [Full Text] [Related]

  • 10. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 11. High regression rate of coronary aneurysms developed in patients with immune globulin-resistant Kawasaki disease treated with steroid pulse therapy.
    Adachi S, Sakaguchi H, Kuwahara T, Uchida Y, Fukao T, Kondo N.
    Tohoku J Exp Med; 2010 Apr; 220(4):285-90. PubMed ID: 20410679
    [Abstract] [Full Text] [Related]

  • 12. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF, Beijing Kawasaki Disease Epidemilogy Study Grou.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3119-21. PubMed ID: 18269869
    [Abstract] [Full Text] [Related]

  • 13. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
    Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL.
    J Microbiol Immunol Infect; 2005 Apr 27; 38(2):149-52. PubMed ID: 15843862
    [Abstract] [Full Text] [Related]

  • 14. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 15. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
    Wright DA, Newburger JW, Baker A, Sundel RP.
    J Pediatr; 1996 Jan 15; 128(1):146-9. PubMed ID: 8551407
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

  • 17. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
    Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, Yamagishi H.
    Arch Dis Child; 2005 Oct 28; 90(10):1096-7. PubMed ID: 16177169
    [No Abstract] [Full Text] [Related]

  • 18. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC.
    J Pediatr; 2006 Sep 28; 149(3):291-2. PubMed ID: 16939734
    [No Abstract] [Full Text] [Related]

  • 19. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
    Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M.
    Eur J Pediatr; 2008 Oct 28; 167(10):1119-23. PubMed ID: 18175148
    [Abstract] [Full Text] [Related]

  • 20. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease.
    Seki M, Kobayashi T, Kobayashi T, Morikawa A, Otani T, Takeuchi K, Ayusawa M, Tsuchiya K, Yasuda K, Suzuki T, Shimoyama S, Ikeda K, Ishii Y, Arakawa H.
    Pediatr Infect Dis J; 2011 Feb 28; 30(2):145-7. PubMed ID: 20802375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.